Central role of complement membrane attack complex in monosodium urate crystal-induced neutrophilic rabbit knee synovitis

被引:57
作者
Tramontini, N
Huber, C
Liu-Bryan, R
Terkeltaub, RA
Kilgore, KS
机构
[1] Pfizer Global Res & Dev, Ann Arbor, MI USA
[2] Vet Affairs Med Ctr, San Diego, CA 92161 USA
[3] Univ Calif San Diego, San Diego, CA 92103 USA
来源
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 08期
关键词
D O I
10.1002/art.20386
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Monosodium urate monohydrate (MSU) crystals promote gouty inflammation that is critically mediated by neutrophil recruitment and activation. Interleukin-8 (IL-8) and closely related chemokines are major neutrophil chemotaxins in experimental gout. But MSU crystals also activate the classical and alternative pathways of complement, and MSU crystals directly cleave C5 on the crystal surface. Unlike IL-8, the roles in acute gout of individual complement-derived peptides and of the terminal C5b-9 complement components that comprise the membrane attack complex (MAC) are unclear. Hence, we studied rabbits deficient in the MAC component C6 to determine if MAC mediated urate crystal-induced arthritis. Methods. We injected C6-deficient and C6-sufficient rabbit knee joints with 10 mg of pyrogen-free urate crystals and analyzed IL-8 levels, leukocyte influx, and joint inflammation 24 hours later. Results. There was a significant decrease (> 60%) in swelling in MSU crystal-injected knees of C6-deficient animals as compared with C6-sufficient animals (P < 0.05). An attenuated rise in MSU crystal-induced joint effusion levels of IL-8 also was observed, which was concordant with diminished numbers of neutrophils (P < 0.05) but not monocytes in MSU crystal-induced knee synovial fluid from C6-deficient animals. Synovial tissue analysis confirmed mononuclear leukocyte infiltration in response to MSU crystal injection in all animals, but substantial neutrophil infiltration only in C6-sufficient animals. Conclusion. MAC activation appears to play a major role in intraarticular IL-8 generation and in neutrophil recruitment in experimental acute gouty arthritis of the rabbit knee. C6 and MAC activation may represent novel therapeutic targets for suppression of neutrophil-mediated joint inflammation in gout.
引用
收藏
页码:2633 / 2639
页数:7
相关论文
共 53 条
[1]   SYNOVITIS OF ACUTE GOUTY ARTHRITIS - LIGHT AND ELECTRON-MICROSCOPIC STUDY [J].
AGUDELO, CA ;
SCHUMACHER, HR .
HUMAN PATHOLOGY, 1973, 4 (02) :265-279
[2]   Decay-accelerating factor induction by tumour necrosis factor-α, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition [J].
Ahmad, SR ;
Lidington, EA ;
Ohta, R ;
Okada, N ;
Robson, MG ;
Davies, KA ;
Leitges, M ;
Harris, CL ;
Haskard, DO ;
Mason, JC .
IMMUNOLOGY, 2003, 110 (02) :258-268
[3]   Mechanisms of effects of complement inhibition in murine collagen-induced arthritis [J].
Banda, NK ;
Kraus, D ;
Vondracek, A ;
Huynh, LH ;
Bendele, A ;
Holers, VM ;
Arend, WP .
ARTHRITIS AND RHEUMATISM, 2002, 46 (11) :3065-3075
[4]   Endotoxin-induced lung inflammation is independent of the complement membrane attack complex [J].
Brauer, RB ;
Gegenfurtner, C ;
Neumann, B ;
Stadler, M ;
Heidecke, CD ;
Holzmann, B .
INFECTION AND IMMUNITY, 2000, 68 (03) :1626-1632
[5]  
Chapman PT, 1996, BRIT J RHEUMATOL, V35, P323
[6]   NONINVASIVE IMAGING OF E-SELECTIN EXPRESSION BY ACTIVATED ENDOTHELIUM IN URATE CRYSTAL-INDUCED ARTHRITIS [J].
CHAPMAN, PT ;
JAMAR, F ;
HARRISON, AA ;
BINNS, RM ;
PETERS, AM ;
HASKARD, DO .
ARTHRITIS AND RHEUMATISM, 1994, 37 (12) :1752-1756
[7]   UP-REGULATION OF COMPLEMENT REGULATORS MCP (CD46), DAF (CD55) AND PROTECTIN (CD59) IN ARTHRITIC JOINT DISEASE [J].
DAVIES, ME ;
HORNER, A ;
LOVELAND, BE ;
MCKENZIE, IFC .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1994, 23 (06) :316-321
[8]  
Doerschuk CM, 1996, J IMMUNOL, V157, P4609
[9]   ACTIVATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT BY MONOSODIUM URATE CRYSTALS [J].
FIELDS, TR ;
ABRAMSON, SB ;
WEISSMANN, G ;
KAPLAN, AP ;
GHEBREHIWET, B .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1983, 26 (02) :249-257
[10]  
GICLAS PC, 1979, J CLIN INVEST, V63, P759, DOI 10.1172/JCI109360